Buch, Englisch, 240 Seiten, Gewicht: 450 g
Volume 49-1
Buch, Englisch, 240 Seiten, Gewicht: 450 g
ISBN: 978-0-323-84928-9
Verlag: Elsevier Health Sciences
In this issue of Rheumatic Disease Clinics, guest editors Drs. M. Elaine Husni? and George A. Karpouzas bring their considerable expertise to the topic of Cardiovascular Complications of Chronic Rheumatic Diseases. Top experts in the field cover key topics such as primary and secondary atherosclerotic cardiovascular (ASCVD) risk prevention in the rheumatic disease, pro-thrombotic and pro-atherogenic anti-phospholipid antibodies, recommendations for the use of NSAIDs and CVD risk, and more. -
Contains 9 relevant, practice-oriented topics including atherosclerotic cardiovascular risk stratification in the rheumatic diseases; subclinical atherosclerosis evaluation across various vascular territories; lessons from heart and large vessel biopsies in patients with and without autoimmune rheumatic disease; the role of lipoprotein levels and function in atherosclerosis associated with autoimmune rheumatic diseases; and more.
-
Provides in-depth clinical reviews on cardiovascular complications of chronic rheumatic diseases, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
Time Trends of Cardiovascular Disease in the General Population and Inflammatory Arthritis
Atherosclerotic Cardiovascular Risk Stratification in the Rheumatic Diseases: An Integrative, Multiparametric Approach
Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases
Heart Failure in Rheumatic Disease: Secular Trends and Novel Insights
Cardiovascular Disease in Large Vessel Vasculitis: Risks, Controversies, and Management Strategies
Venous Thromboembolism in the Inflammatory Rheumatic Diseases
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases
Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases
Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk: Decades Later, Any New Lessons Learned?
